ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Clinical Trials, Centers Would Be First In Line For Money Added To Budget, Broder Tells Congress

March 31, 1989

Feds Should Lead Quality Improvement In Government Health Programs, IOM Report Says

November 8, 2002

Comprehensive Center NCAB Evaluations

June 2, 1978

Millers Win Bristol-Myers $25,000 Award

May 19, 1978

Responses So Far Support Outstanding Investigator Grant; NCAB Members Object To Salary commitment

July 8, 1983

Professional Societies: AACR Presents Awards At Annual Meeting

April 18, 1997